Philip D. Greenberg, M.D.

Professor of Oncology and Immunology, University of Washington; Investigator, Parker Institute for Cancer Immunotherapy, Fred Hutchinson Cancer Research Center

Immunology, Immuno-oncology, Cancer Biology, Genetic Engineering, Cell Therapy

EDUCATION

BA - Washington University, St. Louis

MD - State University of New York

Residency - University of California, San Diego

Postdoctoral Fellow - University of California, San Diego  

AWARDS AND ACCOLADES

American Society of Clinical Investigation Fellow

Association of American Physicians Fellow

American Association for the Advancement of Science Fellow

Cancer Research Institute’s William B. Coley Award for Distinguished Research in Tumor Immunology

Society for Immunotherapy of Cancer Richard Smalley Memorial Award

Fellow of the American Association for Cancer Research Academy

Distinguished Fellow of the American Association of Immunologists

American Society of Hematology E. Donnall Thomas Prize for Pioneering Research Achievements in Hematology

Precision Medicine World Conference (PMWC) Luminary Award

COMPANIES AND BOARDS

Co-Founder: Targeted Genetics (NASDAQ: TGEN), Juno Therapeutics (acquired by Celgene), Affini-T Therapeutics

Board of Directors: Nestle SA, Vilcek Foundation

Scientific Advisory Board: Celsius Therapeutics, Earli, Immunoscpate, Metagenomi, Elpiscience Biopharma

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.